Related references
Note: Only part of the references are listed.The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data
Ivana Bozovic-Spasojevic et al.
CLINICAL CANCER RESEARCH (2017)
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
Karin Elebro et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The Androgen Receptor: Is It a Promising Target?
Ayca Gucalp et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2016)
Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences
Marit Valla et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
A proposal for validation of antibodies
Mathias Uhlen et al.
NATURE METHODS (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
C. Parker et al.
ANNALS OF ONCOLOGY (2015)
Androgen receptor status is highly conserved during tumor progression of breast cancer
Andre Grogg et al.
BMC CANCER (2015)
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C. U. Cheang et al.
ONCOLOGIST (2015)
Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung
Yukinori Hattori et al.
PATHOLOGY INTERNATIONAL (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
Jung Eun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Androgen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers
Julia Y. S. Tsang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The value of archival tissue blocks in understanding breast cancer biology
Thomas Dowsett et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
Pierluigi Gasparini et al.
PLOS ONE (2014)
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
M. J. Engstrom et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
E. H. Lips et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer
Yukiko Shibahara et al.
HUMAN PATHOLOGY (2013)
The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis
Qing Qu et al.
PLOS ONE (2013)
Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy
Naoko Honma et al.
BREAST CANCER (2013)
Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2012)
The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
Dabei Tang et al.
MEDICAL ONCOLOGY (2012)
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
Jiehua He et al.
MEDICAL ONCOLOGY (2012)
Expression of androgen receptor in breast cancer and its significance as a prognostic factor
Q. Yu et al.
ANNALS OF ONCOLOGY (2011)
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
S. Park et al.
ANNALS OF ONCOLOGY (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Effects of Long-Term Storage on the Detection of Proteins, DNA, and mRNA in Tissue Microarray Slides
Christina Karlsson et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Expression of Nuclear Receptor DAX-1 and Androgen Receptor in Human Breast Cancer
Byung Joo Chae et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Expression of androgen receptors in primary breast cancer
S. Park et al.
ANNALS OF ONCOLOGY (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site
Ja Seung Koo et al.
TUMORI JOURNAL (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Amelia A. Peters et al.
CANCER RESEARCH (2009)
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen et al.
EUROPEAN JOURNAL OF CANCER (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Influence of slide aging on results of translational research studies using immunohistochemistry
M Mirlacher et al.
MODERN PATHOLOGY (2004)
Androgen receptors frequently are expressed in breast carcinomas - Potential relevance to new therapeutic strategies
F Moinfar et al.
CANCER (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
